PATENT CLAIM ANALYSIS

Application Number: 15972943
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-03
Patent Classification: ["424", "468000"]

Abstract:
A once-a-day controlled release oral dosage form of methazolamide is provided. The dosage form comprises a therapeutically effective amount of methazolamide and a high molecular weight binder. The dosage is configured for once-daily administration to a subject in need thereof, and releases methazolamide over a period of about twenty-four hours.

Claim (Index 14):
The controlled release oral dosage form of  claim 13 , wherein the filler is lactose, and wherein the lubricant is magnesium stearate.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 93.0
- Lexical Diversity: 1.38462
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15621298', '12499034', '12378586', '12914054', '10569862']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.766734547993209
- 35 USC 102 Novelty (BERT): 0.5646992247375724
- Combined Prediction Score: 0.7465310156676453
- Mean Citation Score: 294.003498
- Max Citation Score: 471.50354
- Similarity Product: 348.26795100519297

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test